Literature DB >> 3434106

Parathyroid lipoadenoma: a rare cause of primary hyperparathyroidism. Case report.

P Udén1, J Berglund, B Zederfeldt, P Aspelin, O Ljungberg.   

Abstract

Three patients with lipoadenoma of the parathyroid gland are reported. This rare tumour was encountered at surgical exploration for primary hyperparathyroidism in two patients and as an incidental finding at autopsy in the third patient. In the 2 operated patients the lipoadenoma was the cause of primary hyperparathyroidism and they were both cured by extirpation of the tumour. In the autopsy case there was no evidence of excessive parathyroid hormonal activity. The dominating stromal component of all three cases was abundant adult adipose tissue interspersed with epithelial trabeculae of mainly chief cells.

Entities:  

Mesh:

Year:  1987        PMID: 3434106

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  5 in total

1.  A parathyroid myxoadenoma observed grossly.

Authors:  Shabin S Nanji; Sanford I Roth
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

2.  Ectopic atypical parathyroid lipoadenoma: a rare cause of severe primary hyperparathyroidism.

Authors:  Vivienne Yoon; Kristina Treat; Naim M Maalouf
Journal:  J Bone Miner Metab       Date:  2012-12-22       Impact factor: 2.626

3.  Parathyroid Lipoadenoma: a Clinicopathological Diagnosis and Possible Trap for the Unaware Pathologist.

Authors:  Martin D Hyrcza; Pınar Sargın; Ozgur Mete
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

4.  Parathyroid Lipoadenoma: A Rare Entity.

Authors:  Ajay Aggarwal; Roopak Wadhwa; Vivek Aggarwal
Journal:  Indian J Endocrinol Metab       Date:  2018 Jan-Feb

5.  Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years.

Authors:  C Christofer Juhlin; Henrik Falhammar; Jan Zedenius; Inga-Lena Nilsson; Anders Höög
Journal:  Endocr Pathol       Date:  2020-06       Impact factor: 3.943

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.